The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Unraveling clonal hematopoiesis of indeterminate potential (CHIP) in cancer: Prevalence, clonal dynamics, and prognostic significance.
 
Ana Pérez González
Honoraria - AbbVie; Astellas Amgen BioPharama; Vertex
Travel, Accommodations, Expenses - Abbvie
 
Claudia Pellín Jou
No Relationships to Disclose
 
Pamela Acha
No Relationships to Disclose
 
Victor Navarro
No Relationships to Disclose
 
Laura Palomo
No Relationships to Disclose
 
Oriol Calvete
No Relationships to Disclose
 
Iosune Baraibar
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - Amgen; Merck; SERVIER
 
Nadia Saoudi Gonzalez
Speakers' Bureau - AMGEN
 
Esther Zamora
No Relationships to Disclose
 
Lucia Sanz
Travel, Accommodations, Expenses - Pfizer
 
Lorena Fariñas-Madrid
No Relationships to Disclose
 
Irene Brana
Consulting or Advisory Role - AstraZeneca; Bicara Therapeutics; Boehringer Ingelheim; Boehringer Ingelheim Spain; Cancer Expert Now; Gilead Sciences; Merck Sharp & Dohme; Merus
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; MSD
Research Funding - AOP Health (Inst); AstraZeneca (Inst); Bicara Therapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Debiopharm Group (Inst); Dragonfly Therapeutics (Inst); Epizyme (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Gliknik (Inst); Hookipa Pharma (Inst); IDEAYA Biosciences (Inst); Immutep (Inst); ISA Pharmaceuticals (Inst); Janssen Oncology (Inst); Kura Oncology (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Merus (Inst); Nanobiotix (Inst); Northern Biologics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Regeneron (Inst); Roche (Inst); Seagen (Inst); Seagen (Inst); Shattuck Labs (Inst); Tango Therapeutics (Inst); Tolremo (Inst); VCN Biosciences (Inst)
 
Macarena Gonzalez
Consulting or Advisory Role - Bayer; Ipsen
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Lilly; Lilly; Novartis; Pfizer; Pierre Fabre; Roche
 
Francesc Ristol
No Relationships to Disclose
 
Maria Diez-Campelo
Honoraria - Abbvie; Bristol-Myers Squibb/Celgene; Keros Therapeutics; Novartis
Consulting or Advisory Role - AGIOS; Ascentage Pharma; Bristol-Myers Squibb/Celgene; Curis; GlaxoSmithKline; HEMAVAN; Keros Therapeutics; Otsuka; Syros Pharmaceuticals
Travel, Accommodations, Expenses - Gilead Sciences; Novartis
 
Ana Alfonso-Pierola
No Relationships to Disclose
 
Francesc Bosch
No Relationships to Disclose
 
Julia Montoro
No Relationships to Disclose
 
David Valcárcel
Consulting or Advisory Role - Amgen; BMS; Celgene; GlaxoSmithKline; Jazz Pharmaceuticals; NOVARTIS; Pfizer; Sanofi; SOBI; Takeda
Speakers' Bureau - Amgen; Astellas Pharma; Astellas Pharma; BMS; Celgene; Gebro Pharma; GlaxoSmithKline; Jazz Pharmaceuticals; Kite, a Gilead company; Novartis; Pfizer; Sanofi/Aventis; SOBI
Travel, Accommodations, Expenses - Amgen; Celgene; GlaxoSmithKline; Jazz Pharmaceuticals; Pfizer